Nova Patents
AT346598T

1-aminoindan derivatives and compositions thereof

Abstract

(57) The new derivatives and these salt of a summary 1* amino indan are indicated. It is treated when Parkinson's disease, dementia, 癲癇, a spasm, a fit, an acute moral traumatic disease, or nerve externally caused injury prescribes the compound of formula (I) for the patient.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

41 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
17953994United States of AmericaA
17960794United States of AmericaA

Members41

Family members, oldest first
DocumentOfficeKind
IL112292D0IsraelD0
CA2180841A1CanadaA1
WO9518617A1World Intellectual Property Organization (WIPO)A1
AU1867095AAustraliaA
ZA95144BSouth AfricaB
IL116748D0IsraelD0
NO962842D0NorwayD0
WO9621640A1World Intellectual Property Organization (WIPO)A1
ZA96211BSouth AfricaB
AU4896096AAustraliaA
NO962842LNorwayL
HU9601888D0HungaryD0
EP0738149A1European Patent Office (EPO)A1
HUT75067AHungaryA
US5639913AUnited States of AmericaA
JPH09510188AJapanA
US5877218AUnited States of AmericaA
US5877221AUnited States of AmericaA
US5880159AUnited States of AmericaA
US5914349AUnited States of AmericaA
EP0738149A4European Patent Office (EPO)A4
US5994408AUnited States of AmericaA
IL112292AIsraelA
IL134346D0IsraelD0
IL134347D0IsraelD0
IL134348D0IsraelD0
IL134349D0IsraelD0
US6271263B1United States of AmericaB1
US2002068839A1United States of AmericaA1
IL116748AIsraelA
US6528685B2United States of AmericaB2
NO315594B1NorwayB1
IL134349AIsraelA
EP0738149B1European Patent Office (EPO)B1
AT346598TThis recordAustriaT
ATE346598T1AustriaT1
DE69535315D1GermanyD1
CA2180841CCanadaC
DE69535315T2GermanyT2
HU225986B1HungaryB1
JP4782252B2JapanB2